PubMed

Brief communication: Successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab).

Sloand EM, Scheinberg P, Maciejewski J, Young NS.

Ann Intern Med. 2006 Feb 7;144(3):181-5.PMID: 16461962 [PubMed - indexed for MEDLINE]Related articlesFree article

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia.

Maciejewski JP, Sloand EM, Nunez O, Boss C, Young NS.

Blood. 2003 Nov 15;102(10):3584-6. Epub 2003 Jul 24.PMID: 12881307 [PubMed - indexed for MEDLINE]Related articlesFree article

Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.

Elimelakh M, Dayton V, Park KS, Gruessner AC, Sutherland D, Howe RB, Reding MT, Eastlund T, van Burik JA, Singleton TP, Gruessner RW, Key NS.

Haematologica. 2007 Aug;92(8):1029-36. Epub 2007 Jul 20.PMID: 17640860 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R.

Arch Neurol. 2009 Apr;66(4):483-9.PMID: 19364933 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).

Ru X, Liebman HA.

Br J Haematol. 2003 Oct;123(2):278-81.PMID: 14531909 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.

Ghazal H.

Blood. 2002 Feb 1;99(3):1092-4.PMID: 11807020 [PubMed - indexed for MEDLINE]Related articlesFree article

Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.

Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR.

Ophthalmology. 2005 May;112(5):764-70.PMID: 15878055 [PubMed - indexed for MEDLINE]Related articles

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.

Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ.

Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70.PMID: 17558830 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.

Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB.

J Autoimmun. 2008 Sep;31(2):91-7. Epub 2008 Jun 20.PMID: 18571896 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, Kopera M, Kruzel T, Najda J, Nowak K, Holowiecki J.

Haematologica. 2005 Nov;90 Suppl:ECR33.PMID: 16266924 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.

Waldmann TA.

J Clin Immunol. 2007 Jan;27(1):1-18. Epub 2007 Jan 11. Review.PMID: 17216565 [PubMed - indexed for MEDLINE]Related articles

Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?

Van Gelder T, Warlé M, Ter Meulen RG.

Drugs. 2004;64(16):1737-41. Review.PMID: 15301558 [PubMed - indexed for MEDLINE]Related articles

Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.

Carracedo J, Madueño JA, Ramirez R, Martin-Malo A, de Francisco AL, Aljama P; Spanish Society of Nephrology.

J Nephrol. 2005 Jul-Aug;18(4):382-7.PMID: 16245241 [PubMed - indexed for MEDLINE]Related articles

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.

Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR.

J Autoimmun. 2003 Nov;21(3):283-93. Erratum in: J Autoimmun. 2004 Aug;23(1):93. PMID: 14599854 [PubMed - indexed for MEDLINE]Related articles

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.

Zecca M, De Stefano P, Nobili B, Locatelli F.

Blood. 2001 Jun 15;97(12):3995-7.PMID: 11389047 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.

Krueger JG, Walters IB, Miyazawa M, Gilleaudeau P, Hakimi J, Light S, Sherr A, Gottlieb AB.

J Am Acad Dermatol. 2000 Sep;43(3):448-58.PMID: 10954656 [PubMed - indexed for MEDLINE]Related articles

A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis.

Van Assche G, Dalle I, Noman M, Aerden I, Swijsen C, Asnong K, Maes B, Ceuppens J, Geboes K, Rutgeerts P.

Am J Gastroenterol. 2003 Feb;98(2):369-76.PMID: 12591057 [PubMed - indexed for MEDLINE]Related articles

Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.

Egan CA, Brown M, White JD, Yancey KB.

Clin Immunol. 2001 Nov;101(2):146-51.PMID: 11683573 [PubMed - indexed for MEDLINE]Related articles

Thirty-nine cases of pure red cell aplasia: a single center experience from India.

Srinivas U, Mahapatra M, Saxena R, Pati HP.

Hematology. 2007 Jun;12(3):245-8.PMID: 17558701 [PubMed - indexed for MEDLINE]Related articles

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease.

Przepiorka D, Kernan NA, Ippoliti C, Papadopoulos EB, Giralt S, Khouri I, Lu JG, Gajewski J, Durett A, Cleary K, Champlin R, Andersson BS, Light S.

Blood. 2000 Jan 1;95(1):83-9.PMID: 10607689 [PubMed - indexed for MEDLINE]Related articlesFree article